Current Topics in Pharmacology 2003-2004 Schedule
Meets: Wednesdays 12:30 PM
Room: T-473 HSB
| October | 1 | Stanley McKnight, Typos Can Neutralize a WMD |
| 8 | Travis Biechele, How the COPs Know Who to Haul Away | |
| 15 | Paige Cundiff, Taking a Detour in the Amyloid Cascade Hypothesis: The Road to Recovering Memories Lost in Alzheimer's Disease. | |
| 22 | Alexandra Few, NCS-1: a Sensitive Sensor of Calcium and its Role in Short-term Facilitation of Synaptic Transmission | |
| 29 | Seth Goldenberg, King of the PAK; Recent Advances in the Regultaion of Group II p21-activated Kinases (PAKs) | |
| November | 5 | Kaori Ikeda, Neuroligins and Neurexins in Synaptogenesis |
| 12 | Tom Hinds, Parkinson's Disease: A Case for Cyclooxygenase Involvement in Neurodegeneration | |
| 19 | Martha Port, No Signaling in Plants | |
| 26 | Paul Amieux, Heterochromatin: There's More Going On Than Meets The Eye | |
| December | 3 | Nephi Stella, An Obituary for Apoptosis |
| 10 | Charles Chavkin, How Far Have We Come in Understanding the Neurological Basis of Schizophrenia? | |
| January | 7 | William Catterall, Anions Do It Differently: Structure, Function, and Genetic Diseases of Chloride Channels |
| 14 | Kristin Mahan, The Flip Side of Prions: How Translational Activator CPEB May Enhance Synaptic Plasticity Due to its Prion-like Properties. | |
| 21 | Eiron Cudaback, A Potpourri of Pluripotency: News from the Neural Stem Cell Front | |
| 28 | ||
| February | 4 | Laura Beth Johnson, Prostaglandin Production in Gliomas: Enhancing Cancer Treatment with COX-2 Inhibitors |
| 11 | Lorna Kategaya, Insulin Signalling and Sex Determination | |
| 18 | Sunil Laxman, Specificity in Signaling Domains and Scaffolds: Molecular Monogamy | |
| 25 | Paul Muchowski, Why it's Fun to FRET: A Phat Foray into Fluorescence Techniques to Study Signaling | |
| March | 3 | Randall Moon Mathematical Modeling of Signal Transduction Pathways Made Easy (well, easier) |
| 10 | Janet Lowe Psychotic Phosphatases: A Potential Role for Phosphatases and Their Inhibitors in Schizophrenia | |
| 31 | Jennifer Wacker Recent Strategies to Prevent or Delay the Development of Prion Disease | |
| April | 7 | Joseph Beavo, For Whom the Cells Toll: New Roles for New Receptors |
| 14 | Misty Marshall, Dendritic Spine Changes, AMPA Receptor Trafficking and Synapse Unsilencing - Molecular Models of LTP | |
| 21 | Edith Wang, Do flies get cancer? Modeling Transformation and Metastasis in Drosophila | |
| 28 | None | |
| May | 5 | Neil Nathanson, When Good Factors Go BAD: NGF Kills Like a PRO |
| 12 | ||
| 19 | ||
| 26 | Open | |
| June | 2 | JP Jones, SMaRT RNAs Can Learn New Tricks |